Last edition
News about "bladder cancer "
US FDA Approves PADCEV plus Keytruda for Certain Patients with Bladder Cancer
PADCEV plus Keytruda is the first and only approved perioperative treatment regimen that can improve survival over current standard of care (surgery alone) in cisplatin-ineligible patients with Muscle-Invasive Bladder Cancer (MIBC).
Bladder Cancer | 24/11/2025 | By Dineshwori
Lightpoint Performs World's First Bladder Cancer SLN Procedure with SENSEI
Lightpoint Surgical Ltd., an affiliate of Telix Pharmaceuticals Ltd. has achieved a new milestone with world’s first bladder cancer sentinel lymph node (SLN) procedure with SENSEI
Bladder Cancer | 27/03/2024 | By Manvi | 459
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy